 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
15 News |  |
- | ponezumab (PF-04360365) / Pfizer
Enrollment change: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - May 9, 2016
P2, N=36, Completed, Sponsor: Pfizer
N=57 --> 36
- ||| ponezumab (PF-04360365) / Pfizer
Enrollment change: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Mar 9, 2016
P2, N=57, Completed, Sponsor: Pfizer
N=57 --> 36 N=36 --> 57
- | ponezumab (PF-04360365) / Pfizer
Trial completion: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Feb 9, 2016
P2, N=36, Completed, Sponsor: Pfizer
N=36 --> 57 Active, not recruiting --> Completed
- | ponezumab (PF-04360365) / Pfizer
Enrollment closed: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Apr 22, 2015
P2, N=36, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ponezumab (PF-04360365) / Pfizer
Trial primary completion date: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Oct 10, 2014
P2, N=36, Recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> Jul 2015
- ponezumab (PF-04360365) / Pfizer
Trial primary completion date: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Aug 15, 2014
P2, N=36, Recruiting, Sponsor: Pfizer
Trial primary completion date: Jan 2015 --> Jul 2015 Trial primary completion date: Oct 2014 --> Jan 2015
- | ponezumab (PF-04360365) / Pfizer
Enrollment open: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Sep 22, 2013
P2, N=36, Recruiting, Sponsor: Pfizer
Trial primary completion date: Oct 2014 --> Jan 2015 Active, not recruiting --> Recruiting
- | ponezumab (PF-04360365) / Pfizer
New P2 trial: Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy (clinicaltrials.gov) - Mar 27, 2013
P2, N=36, Recruiting, Sponsor: Pfizer
- | ponezumab (PF-04360365) / Pfizer
Trial completion: Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers (clinicaltrials.gov) - Sep 24, 2012
P1, N=17, Completed, Sponsor: Pfizer
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- |||| ponezumab (PF-04360365) / Pfizer
Trial completion: Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease (clinicaltrials.gov) - Sep 26, 2011
P2, N=198, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ponezumab (PF-04360365) / Pfizer
Trial completion: Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease (clinicaltrials.gov) - Aug 10, 2011
P1, N=8, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed